Elvitegravir Prednisolone 240

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Clinical Effects

Potential for increased risk of adrenal insufficiency and Cushing's syndrome, but PK / PD less affected by strong CYP3A4 inhibitors

Management

If coadministering for systemic use, monitor for adrenal insufficiency and Cushing's syndrome. Do not coadminister if prednisolone needed for local injections.

Import ID
240